Amalgamated Bank Kiniksa Pharmaceuticals, Ltd. Transaction History

Amalgamated Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$17.63 - $21.74 $29,600 - $36,501	-1,679 Reduced 62.32%	1,015 $20,000
Q4 2023 Feb 06, 2024	SELL	$14.37 - $19.07 $4,339 - $5,759	-302 Reduced 10.08%	2,694 $47,000
Q2 2023 Aug 11, 2023	SELL	$10.44 - $16.48 $12,611 - $19,907	-1,208 Reduced 28.73%	2,996 $42,000
Q1 2023 May 02, 2023	SELL	$10.7 - $15.79 $7,019 - $10,358	-656 Reduced 13.5%	4,204 $45,000
Q3 2022 Nov 09, 2022	BUY	$9.76 - $13.41 $702 - $965	72 Added 1.5%	4,860 $62,000
Q2 2022 Aug 15, 2022	BUY	$7.6 - $11.41 $5,282 - $7,929	695 Added 16.98%	4,788 $46,000
Q1 2022 Aug 25, 2022	BUY	$9.3 - $12.37 $38,064 - $50,630	4,093 New	4,093 $41,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $751M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.